4.6 Article

Targeted Elimination of G Proteins and Arrestins Defines Their Specific Contributions to Both Intensity and Duration of G Protein-coupled Receptor Signaling

期刊

JOURNAL OF BIOLOGICAL CHEMISTRY
卷 291, 期 53, 页码 27147-27159

出版社

AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC
DOI: 10.1074/jbc.M116.754887

关键词

-

资金

  1. Biotechnology and Biological Sciences Research Council [BB/K019864/1, BB/K019856/1]
  2. PRESTO, Japan Science and Technology Agency
  3. Biotechnology and Biological Sciences Research Council [1653478, BB/K019856/2, BB/L02781X/1, BB/K019864/1, BB/K019856/1] Funding Source: researchfish
  4. BBSRC [BB/K019864/1, BB/K019856/2, BB/L02781X/1, BB/K019856/1] Funding Source: UKRI

向作者/读者索取更多资源

G protein-coupled receptors (GPCRs) can initiate intracellular signaling cascades by coupling to an array of heterotrimeric G proteins and arrestin adaptor proteins. Understanding the contribution of each of these coupling options to GPCR signaling has been hampered by a paucity of tools to selectively perturb receptor function. Here we employ CRISPR/Cas9 genome editing to eliminate selected G proteins (G alpha(q) and G alpha(11)) or arrestin2 and arrestin3 from HEK293 cells together with the elimination of receptor phosphorylation sites to define the relative contribution of G proteins, arrestins, and receptor phosphorylation to the signaling outcomes of the free fatty acid receptor 4 (FFA4). A lack of FFA4-mediated elevation of intracellular Ca2+ in G alpha q/G alpha(11)-null cells and agonist-mediated receptor internalization in arrestin2/3-null cells confirmed previously reported canonical signaling features of this receptor, thereby validating the genome-edited HEK293 cells. FFA4-mediated ERK1/2 activation was totally dependent on G(q)/(11) but intriguingly was substantially enhanced for FFA4 receptors lacking sites of regulated phosphorylation. This was not due to a simple lack of desensitization of G(q)/(11) signaling because the G(q)/(11)-dependent calcium response was desensitized by both receptor phosphorylation and arrestin-dependent mechanisms, whereas a substantially enhanced ERK1/2 response was only observed for receptors lacking phosphorylation sites and not in arrestin2/3-null cells. In conclusion, we validate CRISPR/Cas9 engineered HEK293 cells lacking G(q)/(11) or arrestin2/3 as systems for GPCR signaling research and employ these cells to reveal a previously unappreciated interplay of signaling pathways where receptor phosphorylation can impact on ERK1/2 signaling through a mechanism that is likely independent of arrestins.

作者

我是这篇论文的作者
点击您的名字以认领此论文并将其添加到您的个人资料中。

评论

主要评分

4.6
评分不足

次要评分

新颖性
-
重要性
-
科学严谨性
-
评价这篇论文

推荐

Article Biochemistry & Molecular Biology

Non-equivalence of Key Positively Charged Residues of the Free Fatty Acid 2 Receptor in the Recognition and Function of Agonist Versus Antagonist Ligands

Eugenia Sergeev, Anders Hojgaard Hansen, Sunil K. Pandey, Amanda E. MacKenzie, Brian D. Hudson, Trond Ulven, Graeme Milligan

JOURNAL OF BIOLOGICAL CHEMISTRY (2016)

Article Biochemistry & Molecular Biology

Dynamic Regulation of Quaternary Organization of the M1 Muscarinic Receptor by Subtype-selective Antagonist Drugs

John D. Pediani, Richard J. Ward, Antoine G. Godin, Sara Marsango, Graeme Milligan

JOURNAL OF BIOLOGICAL CHEMISTRY (2016)

Article Immunology

Evidence for the Existence of a CXCL17 Receptor Distinct from GPR35

Nurul A. S. Binti Mohd Amir, Amanda E. Mackenzie, Laura Jenkins, Karim Boustani, Marston C. Hillier, Tomoko Tsuchiya, Graeme Milligan, James E. Pease

JOURNAL OF IMMUNOLOGY (2018)

Review Neurosciences

Muscarinic receptor oligomerization

Sara Marsango, Richard J. Ward, Elisa Alvarez-Curto, Graeme Milligan

NEUROPHARMACOLOGY (2018)

Article Biochemistry & Molecular Biology

The three α1-adrenoceptor subtypes show different spatio-temporal mechanisms of internalization and ERK1/2 phosphorylation

M. Perez-Aso, V. Segura, F. Monto, D. Barettino, M. A. Noguera, G. Milligan, P. D'Ocon

BIOCHIMICA ET BIOPHYSICA ACTA-MOLECULAR CELL RESEARCH (2013)

Article Biochemistry & Molecular Biology

Defining the Molecular Basis for the First Potent and Selective Orthosteric Agonists of the FFA2 Free Fatty Acid Receptor

Brian D. Hudson, Maria E. Due-Hansen, Elisabeth Christiansen, Anna Mette Hansen, Amanda E. Mackenzie, Hannah Murdoch, Sunil K. Pandey, Richard J. Ward, Rudi Marquez, Irina G. Tikhonova, Trond Ulven, Graeme Milligan

JOURNAL OF BIOLOGICAL CHEMISTRY (2013)

Article Chemistry, Medicinal

Discovery of a Potent and Selective Free Fatty Acid Receptor 1 Agonist with Low Lipophilicity and High Oral Bioavailability

Elisabeth Christiansen, Maria E. Due-Hansen, Christian Urban, Manuel Grundmann, Johannes Schmidt, Steffen V. F. Hansen, Brian D. Hudson, Mohamed Zaibi, Stine B. Markussen, Ellen Hagesaether, Graeme Milligan, Michael A. Cawthorne, Evi Kostenis, Matthias U. Kassack, Trond Ulven

JOURNAL OF MEDICINAL CHEMISTRY (2013)

Article Chemistry, Medicinal

Discovery of TUG-770: A Highly Potent Free Fatty Acid Receptor 1 (FFA1/GPR40) Agonist for Treatment of Type 2 Diabetes

Elisabeth Christiansen, Steffen V. F. Hansen, Christian Urban, Brian D. Hudson, Edward T. Wargent, Manuel Grundmann, Laura Jenkins, Mohamed Zaibi, Claire J. Stocker, Susanne Ullrich, Evi Kostenis, Matthias U. Kassack, Graeme Milligan, Michael A. Cawthorne, Trond Ulven

ACS MEDICINAL CHEMISTRY LETTERS (2013)

Article Cell & Tissue Engineering

Profiling of transcriptional and epigenetic changes during directed endothelial differentiation of human embryonic stem cells identifies FOXA2 as a marker of early mesoderm commitment

Lynsey Howard, Ruth M. Mackenzie, Nikolay A. Pchelintsev, Tony McBryan, John D. McClure, Martin W. McBride, Nicole M. Kane, Peter D. Adams, Graeme Milligan, Andrew H. Baker

STEM CELL RESEARCH & THERAPY (2013)

Article Pharmacology & Pharmacy

The Pharmacology of TUG-891, a Potent and Selective Agonist of the Free Fatty Acid Receptor 4 (FFA4/GPR120), Demonstrates Both Potential Opportunity and Possible Challenges to Therapeutic Agonism

Brian D. Hudson, Bharat Shimpukade, Amanda E. Mackenzie, Adrian J. Butcher, John D. Pediani, Elisabeth Christiansen, Helen Heathcote, Andrew B. Tobin, Trond Ulven, Graeme Milligan

MOLECULAR PHARMACOLOGY (2013)

Meeting Abstract Biochemistry & Molecular Biology

Novel and potent GPR35 agonists aid identification of residues important in ligand interaction

Amanda Elaine Mackenzie, Zaynab Neetoo-Isseljee, Craig Southern, Jeff Jerman, Edward G. McIver, Brian D. Hudson, Debra L. Taylor, Graeme Milligan

FASEB JOURNAL (2013)

Meeting Abstract Biochemistry & Molecular Biology

Defining the molecular mode of binding for α-linolenic acid and the synthetic ligand TUG891 at GPR120

Brian Hudson, Bharat Shimpukade, Trond Ulven, Graeme Milligan

FASEB JOURNAL (2013)

Review Pharmacology & Pharmacy

G protein-coupled receptors not currently in the spotlight: free fatty acid receptor 2 and GPR35

Graeme Milligan

BRITISH JOURNAL OF PHARMACOLOGY (2018)

Article Pharmacology & Pharmacy

The Antiallergic Mast Cell Stabilizers Lodoxamide and Bufrolin as the First High and Equipotent Agonists of Human and Rat GPR35

Amanda E. MacKenzie, Gianluigi Caltabiano, Toby C. Kent, Laura Jenkins, Jennifer E. McCallum, Brian D. Hudson, Stuart A. Nicklin, Lindsay Fawcett, Rachel Markwick, Steven J. Charlton, Graeme Milligan

MOLECULAR PHARMACOLOGY (2014)

暂无数据